About the Joint Action
The general obective of the iPAAC Joint Action (JA) is to develop innovative approaches to advances in cancer control. The innovation that will be covered within the JA consists of further development of cancer prevention, comprehensive approaches to the use of genomics in cancer control, cancer information and registries, improvements and challenges in cancer care, mapping of innovative cancer treatments and governance of integrated cancer control, including a new analysis of National Cancer Control Plans. The key focus of the Joint Action will be on implementation, as reflected in the key deliverable, i.e. the Roadmap on Implementation and Sustainability of Cancer Control Actions, which will support member states in the implementation of iPAAC and CANCON recommendations.
million EUR co-funding by EC
44 partners (Competent Authorities and Affiliated Entities)
08 Apr 2022
iPAAC JA has ended – thank you all
As the iPAAC JA has come to the end, we would like to thank all the partners of the Consortium, our very special thanks go to the Work Package Leaders, who have done a lot of the groundwork in their respective specialised areas. We could not have achieved this much without the strong commitment, dedicated work, and efforts of all partners in the consortium in reaching our joint objectives and completing our deliverables.
10 Jan 2022
iPAAC Joint Action Final Conference
In order to present the main achievements of the iPAAC Joint Action to both partners and a wide range of stakeholders, the Final Conference Cancer Control in Europe: Finding Sustainable Solutions was held on 13-14 December 2021.
02 Sep 2021
Patient pathways for Comprehensive Cancer Care Networks
To coordinate cancer care on the national level and to increase access to quality cancer care, the implementation of Comprehensive Cancer Care Networks (CCCNs) is recommended by the European Guide on Quality Improvement in Comprehensive Cancer Control (CanCon Guide). One of the CCCNs’ tasks is the provision of practical support tools. In this context, comprehensive, integrated patient pathways are recognised as a valuable approach.
28 May 2021
iPAAC partners meet in plenary for the third time
The third iPAAC Joint Action meeting was held online on Wednesday, 17 February 2021. The meeting was attended by the European Commission Representatives, iPAAC Project Partners and iPAAC Work Package Leaders.